Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
Tue, 27.08.2024
Highlight Communications AG
PRESS RELEASE
Highlight Group publishes results for the first half of 2024
Consolidated sales amounted to CHF 182.9 million (previous year: CHF 186.3 million).
The equity ratio amounts to 24.1% (December 31, 2023: 26.8%).
EBIT improved to CHF -5.8 million (previous year CHF -10.4 million).
Pratteln, August 27, 2024 – Consolidated sales and ope [ … ]
Tue, 27.08.2024
North Peak Resources Ltd.
Calgary, Alberta--(Newsfile Corp. - August 27, 2024) - North Peak Resources Ltd. (TSXV: NPR) (the "Company" or "North Peak") announces further assay results from holes 11-17 of the recently completed 27-hole surface drilling program on the west side of the ridge on the Prospect Mountain Property (the "Property") in Eureka, Nevada. The program was t [ … ]
Tue, 27.08.2024
Linde plc
Linde Signs Long-Term Agreement to Supply Clean Hydrogen to Dow’s Path2Zero Project in Canada
Woking, UK, August 27, 2024 – Linde (Nasdaq: LIN) announced today it has signed a long-term agreement for the supply of clean hydrogen to Dow’s Fort Saskatchewan Path2Zero Project. The company will invest more than $2 billion to build, own and operate a w [ … ]
Tue, 27.08.2024
Ananda Development
EQS Newswire / 27/08/2024 / 11:00 CET/CEST
BANGKOK, THAILAND/STUTTGART, GERMANY - Media OutReach Newswire - 27 August 2024 - Porsche Design has announced a collaboration with Thai real estate developer Ananda Development to create the Porsche Design Tower Bangkok. The ultra-luxury residence, located on Sukhumvit 38, is aimed at ultra-high net- [ … ]
Tue, 27.08.2024
United Labels AG
United Labels AG (ISIN: DE 0005489561), one of Europe's leading brand manufacturers in the media/entertainment sector, generated consolidated sales of EUR 10.2 million in the first six months of the 2024 financial year (previous year: EUR 13.3 million). The decline in sales is due to order postponements beyond the reporting date of 30 June 2024. De [ … ]
Tue, 27.08.2024
NEON EQUITY AG
NEON EQUITY: Eva Katheder new member of the Supervisory Board
Frankfurt, August 27, 2024 - NEON EQUITY AG (NEON EQUITY ISIN: DE000A3DW408) announces that the Frankfurt District Court has appointed Eva Katheder as a new member of the Supervisory Board at the company's request. She succeeds Prof. Dr. Karl-Georg Loritz, who has resigned his mandate f [ … ]
Tue, 27.08.2024
ABO Energy GmbH & Co. KGaA
ABO Energy's sustainability performance was rated as "very good" by imug rating. The company received the full 100-point score in two of three categories (“products and services” and “controversies”). The category “ESG management” was rated with 49 of 100 points. The report sees room for improvement in this area. The rating and explanations are ava [ … ]
Tue, 27.08.2024
Nakiki SE
Nakiki SE announces that it is investigating a capital market claim of up to EUR 400,000 against a company listed on the Open Market of the Düsseldorf Stock Exchange. Nakiki is thus opening up a new area of business: the financing of securities law claims.
With this step, Nakiki SE expands its expertise in the area of litigation financing and conti [ … ]
Tue, 27.08.2024
IBU-tec advanced materials AG
IBU-tec witnesses clearly positive signals in the 1st half of 2024
Revenue of EUR 24.8 million roughly equivalent to previous year (previous year: EUR 25.3 million)
EBITDA significantly lower at EUR 0.2 million (previous year: EUR 2.9 million)
Operating cash flow turned positive at +1.6 million euros (previous year: -1.9 million)
Battery mate [ … ]
Tue, 27.08.2024
Dermapharm Holding SE
Dermapharm Holding SE: High-margin existing business in
branded pharmaceuticals segment drives organic growth at
German and international companies
Impressive organic growth in existing branded pharmaceuticals business at German and international companies compensates for drop in revenue due to scheduled end of pandemic-related boom in vaccine [ … ]